FDA Inspection 1292508 — Helixor Heilmittel GmbH
The FDA completed an inspection of Helixor Heilmittel GmbH on September 12, 2025 in Rosenfeld. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 12, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rosenfeld (Germany)